NT5E and rhabdomyosarcoma: Another research group investigated the potential role of CD73 in rhabdomyosarcoma, specifically in fusion-negative rhabdomyosarcoma (FN-RMS), which accounts for over 80% of all rhabdomyosarcoma cases.